Hangzhou Alltest Biotech Co. Ltd. A688606
▲ PositiveCapitalrelevance
Company repurchased shares, signaling confidence and supporting stock price.

Aotai Bio announced that as of July 31, 2026, it had repurchased 3.32 million shares, accounting for 4.18% of total share capital, with a cumulative repurchase amount of 184 million yuan, at a price range of 41.88 yuan to 68.29 yuan per share. In the first quarter of 2026, Aotai Bio achieved revenue of 195 million yuan and net profit attributable to the parent company of 19.39 million yuan.
Hangzhou Alltest Biotech Co. Ltd. ACompany repurchased shares, signaling confidence and supporting stock price.